ACVR1C and ventricular tachycardia: Because Alk7 gene polymorphism has been linked to cardiovascular remodeling in humans [17], our findings in murine cardiomyocytes indicate that ALK7 may serve as a potential therapeutic target for ventricular tachycardia in humans.